Literature DB >> 28509284

AP-VAS 2012 case report: a case of myeloperoxidase antineutrophil cytoplasmic antibody-positive microscopic polyangiitis with rapidly progressive glomerulonephritis and hearing loss.

Maki Tsukamoto1, Seiichiro Shimizu2, Megumi Koizumi3, Nobuo Kitahara3, Yoshihiro Ohtaki4, Shigeyuki Aoki4, Hiroshi Miyakawa5.   

Abstract

A 74-year-old Japanese woman was admitted to our hospital because of fever, fatigue, and hearing loss associated with vertigo. She had a 1-year history of hearing impairment that got worse gradually and had been treated as otitis media with effusion, but without remarkable improvement. After admission, she developed renal dysfunction associated with hematuria and proteinuria. Laboratory tests showed leukocytosis and elevated C-reactive protein. Myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) was elevated, but proteinase-3 antineutrophil cytoplasmic antibody (PR3-ANCA) was negative. Renal biopsy revealed pauci-immune focal necrotizing glomerulonephritis with crescents. She was diagnosed as having MPO-ANCA-associated polyangiitis. After treatment with 500 mg methylprednisolone applied intravenously for 3 days, followed by 40 mg prednisolone administered orally, renal function recovered completely. Her hearing also improved. Although otolaryngological symptoms are common in PR3-ANCA associated vasculitis, hearing loss is a rare manifestation of MPO-ANCA associated vasculitis (MPO-AAV). Our case suggests that AAV should be considered in the differential diagnosis of hearing loss.

Entities:  

Keywords:  Hearing loss; Microscopic polyangiitis; Myeloperoxidase antineutrophil cytoplasmic antibody; Rapidly progressive glomerulonephritis

Year:  2013        PMID: 28509284      PMCID: PMC5411546          DOI: 10.1007/s13730-012-0051-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  10 in total

1.  Clinical features of bilateral progressive hearing loss associated with myeloperoxidase-antineutrophil cytoplasmic antibody.

Authors:  Dai Takagi; Yuji Nakamaru; Shiroh Maguchi; Yasushi Furuta; Satoshi Fukuda
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-05       Impact factor: 1.547

2.  Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing loss.

Authors:  S Maguchi; S Fukuda; E Chida; Y Terayama
Journal:  Auris Nasus Larynx       Date:  2001-05       Impact factor: 1.863

3.  Primary systemic vasculitis: clinical features and mortality.

Authors:  S E Lane; R A Watts; L Shepstone; D G I Scott
Journal:  QJM       Date:  2005-01-17

4.  Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.

Authors:  H K Choi; S Liu; P A Merkel; G A Colditz; J L Niles
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

5.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Authors:  R J Falk; S Hogan; T S Carey; J C Jennette
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

6.  Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.

Authors:  Shouichi Fujimoto; Richard A Watts; Shigeto Kobayashi; Kazuo Suzuki; David R W Jayne; David G I Scott; Hiroshi Hashimoto; Hiroyuki Nunoi
Journal:  Rheumatology (Oxford)       Date:  2011-07-28       Impact factor: 7.580

7.  A patient with myeloperoxidase antineutrophil cytoplasmic antibody-positive polyangiitis who developed sensorineural hearing loss and scleritis.

Authors:  Takafumi Okura; Ken-ichi Miyoshi; Masanori Jotoku; Daijiro Enomoto; Jun Irita; Tomoaki Nagao; Ryoji Ito; Jitsuo Higaki
Journal:  Intern Med       Date:  2011-08-15       Impact factor: 1.271

8.  Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.

Authors:  C Geffriaud-Ricouard; L H Noël; D Chauveau; S Houhou; J P Grünfeld; P Lesavre
Journal:  Clin Nephrol       Date:  1993-03       Impact factor: 0.975

9.  Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis.

Authors:  X Bosch; E Mirapeix; J Font; R Cervera; M Ingelmo; M A Khamashta; L Revert; G R Hughes; A Urbano-Márquez
Journal:  Am J Kidney Dis       Date:  1992-09       Impact factor: 8.860

10.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.